Literature DB >> 23528216

Imbalance of intermediate filament component keratin 14 contributes to increased stress signalling in epidermolysis bullosa simplex.

Martin Wagner, Andrea Trost, Helmut Hintner, Johann W Bauer, Kamil Onder.   

Abstract

An important characteristic of epidermolysis bullosa simplex Dowling-Meara (EBS-DM) keratinocytes is the increased level of Jun N-terminal kinase (JNK) stress signalling, which is thought to contribute to the disease phenotype. In this work, we report on the dramatic up-regulation of cytokeratin 14 (K14) in the EBS-DM model cell line KEB7 at both the transcriptional and translational levels, which is noteworthy because KEB7 patient cells are heterozygous for a missense mutation (R125P) in K14. By performing functional assays, we show a direct link between overexpressed wild-type K14 and increased JNK signalling in healthy, immortalized keratinocytes. This observation led us to hypothesize a positive feedback model in which mutant (R125P) K14 triggers JNK signalling, leading to increased AP1-dependent expression of K14, which in turn amplifies JNK signalling further. We therefore suggest that an imbalance of cytoplasmic K14 monomers and K14 incorporated into the intermediate filament (IF) network leads to elevated stress signalling, potentially altering IF dynamics by phosphorylation, which as a side effect, weakens EBS-DM keratinocytes.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23528216     DOI: 10.1111/exd.12112

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  5 in total

1.  Chemical chaperone therapy, a new strategy for genetic skin fragility disorders.

Authors:  Jean Christopher Chamcheu; Imtiaz A Siddiqui; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2016-03       Impact factor: 3.960

Review 2.  Multiple roles for keratin intermediate filaments in the regulation of epithelial barrier function and apico-basal polarity.

Authors:  Pedro J Salas; Radia Forteza; Anastasia Mashukova
Journal:  Tissue Barriers       Date:  2016-05-02

Review 3.  Epidermolysis bullosa: Advances in research and treatment.

Authors:  Christine Prodinger; Julia Reichelt; Johann W Bauer; Martin Laimer
Journal:  Exp Dermatol       Date:  2019-08-08       Impact factor: 3.960

Review 4.  Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.

Authors:  Nadezhda A Evtushenko; Arkadii K Beilin; Anastasiya V Kosykh; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

5.  Whole-transcriptome gene expression profiling in an epidermolysis bullosa simplex Dowling-Meara model keratinocyte cell line uncovered novel, potential therapeutic targets and affected pathways.

Authors:  Julia Herzog; Raphaela Rid; Martin Wagner; Harald Hundsberger; Andreas Eger; Johann Bauer; Kamil Önder
Journal:  BMC Res Notes       Date:  2015-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.